http://web.archive.org/web/20150713010723id_/http://www.dailymail.co.uk/health/article-2903235/Last-hope-drug-prostate-cancer-patients-axed-NHS-doctors-call-travesty.html

a ‘ last ditch ’ drug for prostate cancer sufferers is to be axed from @entity4 use			1
@entity5 gives men with advanced disease at least three extra months of life – but some have survived three or more years			1
the @entity10 plans to remove the drug from its approved list effective from march because of weak cost - effectiveness			1
although it will remain available for existing patients , doctors will be unable to prescribe it for hundreds of men with the disease			0
a ' last ditch ' drug for prostate cancer sufferers is to be axed from @entity4 use from march this year			1
the chemotherapy drug @entity5 gives men with advanced disease at least three extra months of life - but some have survived for more than three years			1
cancer charities say @entity25 has failed patients ( file photo ) more than 40,000 men are diagnosed with prostate cancer each year in @entity30 , and over 10,000 die of it			1
critics say the @entity30 still lags behind @entity33 , @entity34 and @entity35 in prescribing life - prolonging medicines to cancer patients and the situation will get worse			1
@entity5 is among 25 drugs being re-evaluated by the @entity10 , originally set up to improve access to vital medicines in @entity25 , which will issue a full list of those being de-listed next week			0
the decision to stop @entity4 use of @entity5 – it has already been rejected by the rationing body @entity46 – follows news that six breast cancer drugs prescribed for thousands of women are also set to be axed			0
some men whose prostate cancer has spread will have no other treatment option			2
dr @entity54 , consultant clinical oncologist at @entity55 , said the decision was a travesty			0
she said ‘ as a doctor who treats men with advanced prostate cancer , i am deeply saddened and my patients will be devastated by this decision			1
@entity5 , also called @entity5 is a drug used to treat advanced prostate cancer when the cancer can no longer be controlled by hormonal therapy			2
@entity5 is given to people after they 've already been treated with the chemotherapy drug docetaxel			0
it is usually given in the chemotherapy day unit or during a short stay in hospital , by a chemotherapy nurse			0
source : @entity74 ‘ in my every day experience , @entity5 has given some men with advanced prostate cancer extra time			2
' some of the men that i started to treat with @entity5 3 to 4 years ago are still alive today – and most importantly this time has been of good quality , allowing them to carry on doing the things they enjoy despite their cancer			0
’ the drug costs around £ 22,000 for a one - off course of treatment and about 500 patients a year have got it via the @entity10			2
the £ 280million a year @entity10 ( @entity91 ) which began in april 2011 has led to around 55,000 patients in @entity25 getting drugs banned on the @entity4 by @entity46 , the rationing body			0
the government 's aim , which was a @entity97 election pledge , was to enable @entity4 doctors to prescribe any drug if they believed a cancer patient could benefit			0
@entity25 last year took over administration of the @entity10 , which is due to be wound up in 2016			0
@entity102 , of the prostate cancer patients ’ charity tackle , said ‘ in recent years , earlier diagnosis and better treatments have led to great improvements in the treatment of advanced prostate cancer and in survival			2
prostate cancer is the most common cancer in men in the @entity30 , with over 40,000 new cases diagnosed every year			1
@entity115 , are human prostate cancer cells under the microscope ‘ by removing a key treatment available for this group of patients who are resistant to hormone therapies , @entity25 has failed to honour its commitment to people with cancer who have no other options			0
’ @entity126 , chief executive of @entity127 @entity30 said : ‘ the very fact that cancer drugs face being struck off the government ’s additional funding pot in the first place is a symptom of a much deeper problem : the cancer drug appraisal and funding systems are broken			1
’ @entity10 chair professor @entity137 said ‘ we need to get maximum value for every pound we spend through the @entity10			0
‘ we can no longer sustain a position where we are funding drugs that do n't offer sufficient clinical benefit when drugs that will do more for patients are coming on stream			1

@entity148 gives men with prostate cancer at least three months of life
but some men given the drug have survived three or more years
@entity10 plans to axe drug from its approved list from march
they say it is not cost - effective and does n't offer ' sufficient clinical benefit '
charities say the appraisal system for drugs is broken , failing patients
40,000 men in @entity30 diagnosed each year , over 10,000 die from disease

@entity30:Britain
@entity33:Germany
@entity35:Italy
@entity10:Cancer Drugs Fund
@entity5:Jevtana
@entity4:NHS
@entity25:NHS England
@entity148:Jetvana
@entity102:Sandy Tyndale-Biscoe
@entity97:Tory
@entity115:Picture
@entity74:Macmillan
@entity55:Lancashire Teaching Hospitals NHS Foundation Trust
@entity54:Alison Birtle
@entity126:Owen Sharp
@entity46:Nice
@entity127:Prostate Cancer
@entity137:Peter Clark
@entity91:CDF
@entity34:France